SCHEMBL2989495

SCHEMBL2989495

CC1(CC2C3CCC(C3)C2(C)C)CCC2C(C1)C2(C)C

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3220470 0.76 RET (0.40)
SCHEMBL14721175 0.68 ALDH1A1 (0.45) ALDH1A1NPSR1
SCHEMBL6762552 0.68 ALDH1A1 (0.38) ALDH1A1NPSR1
SCHEMBL6142600 0.66 ALDH1A1 (0.47) ALDH1A1NPSR1
SCHEMBL18503901 0.66 ALDH1A1 (0.47) ALDH1A1NPSR1
SCHEMBL23817169 0.66 ALDH1A1 (0.47) ALDH1A1NPSR1
SCHEMBL10784662 0.65 ALDH1A1 (0.43) ALDH1A1NPSR1
SCHEMBL11466774 0.65 ALDH1A1 (0.43) ALDH1A1NPSR1
SCHEMBL7925194 0.65 ALDH1A1 (0.43) ALDH1A1NPSR1
SCHEMBL10785695 0.64 ALDH1A1 (0.45) ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828283-B2 Traction fluids in toroidal continuously variable transmission (T-CVT) systems GENBERAL MOTORS CORPORATION 2004-12-07 US claimed
US-20040152931-A1 Traction fluid with alkane bridged dimer GM Global Technology Operations LLC 2004-08-05 US claimed
EP-2009304-B1 TORQUE LIMITER JTEKT CORP (JP) 2014-10-01 EP disclosed
EP-2003353-B1 TORQUE LIMITER JTEKT CORP (JP) 2014-06-04 EP disclosed
US-8230986-B2 Torque limiter JTEKT CORPORATION (JP) 2012-07-31 US disclosed
US-8220609-B2 Torque limiter JTEKT CORPORATION (JP) 2012-07-17 US disclosed
US-20100184519-A1 TORQUE LIMITER JTEKT CORPORATION (JP) 2010-07-22 US disclosed
US-20090173591-A1 TORQUE LIMITER JTEKT CORPORATION (JP) 2009-07-09 US disclosed
EP-2009304-A1 TORQUE LIMITER JTEKT Corporation (JP) 2008-12-31 EP disclosed
EP-2003353-A1 TORQUE LIMITER JTEKT Corporation (JP) 2008-12-17 EP disclosed
US-6828283-B2 Traction fluids in toroidal continuously variable transmission (T-CVT) systems GENBERAL MOTORS CORPORATION 2004-12-07 US disclosed
US-20040152931-A1 Traction fluid with alkane bridged dimer GM Global Technology Operations LLC 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152931-A1 Traction fluid with alkane bridged dimer CCL11, CCL2, TLN1 ALDH1A1 2451/4885NPSR1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.